Lördag 3 Maj | 19:23:32 Europe / Stockholm

Kalender

Est. tid*
2025-07-31 07:00 Kvartalsrapport 2025-Q2
2025-05-16 N/A X-dag ordinarie utdelning CRBN 0.64 EUR
2025-05-14 N/A Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-08-08 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning CRBN 0.61 EUR
2024-05-15 - Årsstämma
2024-05-02 - X-dag bonusutdelning CRBN 0.1
2024-03-01 - Bokslutskommuniké 2023
2023-08-10 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning CRBN 0.56 EUR
2023-05-17 - Årsstämma
2023-03-03 - Bokslutskommuniké 2022
2022-08-10 - Kvartalsrapport 2022-Q2
2022-07-05 - Extra Bolagsstämma
2022-05-20 - X-dag ordinarie utdelning CRBN 0.56 EUR
2022-05-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning CRBN 0.56 EUR
2021-05-19 - Årsstämma
2021-04-30 - Kvartalsrapport 2021-Q1
2021-03-05 - Bokslutskommuniké 2020
2020-10-12 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning CRBN 0.56 EUR
2020-06-29 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-01-13 - Bokslutskommuniké 2019
2019-11-01 - Kvartalsrapport 2019-Q3
2019-08-07 - Kvartalsrapport 2019-Q2
2019-08-05 - Extra Bolagsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
2023-12-14 10:55:43

Corbion, the Amsterdam-listed sustainable ingredients company dedicated to preserving what matters, specializing in lactic acid, lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients, today issued the following statement regarding public statements made by Inclusive Capital Partners, L.P. (“Inclusive”):

The Supervisory Board and Management of Corbion value open dialogue with shareholders and welcome their constructive input. We have engaged, and will continue to engage, with Inclusive in a manner consistent with that approach. We remain focused on delivering long-term value to our shareholders and stakeholders, will continue to take actions to achieve that objective and will consider Inclusive’s suggestions.

As we mentioned in our Q3 Interim Management Statement, we are preparing a restructuring program to manifest itself in 2024. This program includes a full review to drive material improvements in operating expenses, capital program and working capital. Next to this we are conducting a strategic review of Corbion’s position in PLA, developing an Algae Ingredients roadmap 2025-2030 following strong growth prospects, and continuing our focus on our high growth, high value biomedical business. A broader auction process is underway to divest the non-core emulsifier business in order to maximize value.

We are looking forward to presenting our plans on 31st January 2024.